S. Hofstraat, A. M. Falla, E. F. Duffell, S. Hahne, A. J. Amato-gauci et al., Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review, Epidemiol Infect, vol.145, issue.14, pp.2873-85, 2017.

J. D. Stanaway, A. D. Flaxman, M. Naghavi, C. Fitzmaurice, T. Vos et al., The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study, The Lancet, vol.388, pp.1081-1089, 2013.

A. Petruzziello, S. Marigliano, G. Loquercio, and C. Cacciapuoti, Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe, Infect Agent Cancer, vol.11, p.53, 2016.

, European Centre for Disease Prevention and Control. Hepatitis C In: ECDC. Annual epidemiological report for, 2016.

, World Health Organization. Global health sector strategy on viral hepatitis 2016-2021 towards ending viral hepatitis. Geneva: World Health Organization, 2016.

, Action plan for the health sector response to viral hepatitis in the WHO European Region. Geneva: World Health Organization, 2016.

J. V. Lazarus, J. Lundgren, J. Casabona, L. Wiessing, C. Mathei et al., Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis, BMC Infect Dis, vol.14, 2014.

J. V. Lazarus, C. Gore, T. Nguyen, K. Safreed-harmon, I. Sperle et al., World Hepatitis Day 2013: Know it, Confront it. The Lancet Global Health, vol.1, p.70038, 2013.

J. Smith, C. Mallouris, K. Lee, and T. Alfven, The Role of Civil Society Organizations in Monitoring the Global AIDS Response, AIDS Behav, vol.21, issue.1, p.27734168, 2017.

M. A. Torres, S. Gruskin, K. Buse, T. Erkkola, V. Bendaud et al., Monitoring HIV-Related Laws and Policies: Lessons for AIDS and Global Health in Agenda 2030, AIDS Behav, vol.21, issue.1, p.28084561, 2017.

J. V. Lazarus, S. R. Stumo, M. Harris, G. Hendrickx, K. L. Hetherington et al., Hep-CORE: a crosssectional study of the viral hepatitis policy environment reported by patient groups in 25 European countries in 2016 and 2017, J Int AIDS Soc, vol.21, issue.2, p.25052, 2018.

, Hep-Core report. Monitoring the implementation of hepatitis B and C policy recommendations in Europe, European Liver Patients Associtation. The, 2016.

J. V. Lazarus, K. Safreed-harmon, S. R. Stumo, M. Jauffret-roustide, M. Maticic et al., Restrictions on access to direct-acting antivirals for people who inject drugs: The European Hep-CORE study and the role of patient groups in monitoring national HCV responses, Int J Drug Policy, vol.47, pp.47-50, 2017.

G. S. Cooke, I. Andrieux-meyer, T. L. Applegate, R. Atun, J. R. Burry et al., Accelerating the elimination of viral hepatitis: a, Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology & Hepatology, vol.4, issue.2, pp.135-84, 2019.

R. Likert, A technique for the measurement of attitudes, Archives of Psychology, vol.22, p.16, 1932.

R. Bielen, S. R. Stumo, R. Halford, K. Werling, T. Reic et al., Harm reduction and viral hepatitis C in European prisons: a cross-sectional survey of 25 countries, Harm Reduct J, vol.15, issue.1, p.29751763, 2018.

A. D. Marshall, J. M. Pawlotsky, J. V. Lazarus, A. Aghemo, G. J. Dore et al., The removal of DAA restrictions in Europe-One step closer to eliminating HCV as a major public health threat, J Hepatol, vol.69, issue.5, pp.1188-96, 2018.

A. D. Marshall, E. B. Cunningham, S. Nielsen, A. Aghemo, H. Alho et al., Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe, The Lancet Gastroenterology & Hepatology, vol.3, issue.2, pp.125-158, 2018.

, Country drug reports: European Monitoring Center for Drugs and Drug Additction, 2018.

D. Franco and G. , Multiple correspondence analysis: one only or several techniques?, Quality & Quantity, vol.50, issue.3, pp.1299-315, 2015.

N. Sourial, C. Wolfson, B. Zhu, J. Quail, J. Fletcher et al., Correspondence analysis is a useful tool to uncover the relationships among categorical variables, J Clin Epidemiol, vol.63, issue.6, pp.638-684, 2010.

M. Greenacre, Correspondence analysis in practice, vol.3, 2017.

M. Mazziotta and A. Pareto, Methods For Constructing Composite Indices: One For All Or All For One? Rivista Italiana di, Economia Demografia e Statistica, vol.67, issue.2, 2013.

J. V. Lazarus, S. Wiktor, M. Colombo, and M. Thursz, Micro-elimination-A path to global elimination of hepatitis C, Journal of hepatology, vol.67, issue.4, pp.665-671, 2017.

J. V. Lazarus, K. Safreed-harmon, M. R. Thursz, J. F. Dillon, M. H. El-sayed et al., The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations, Seminars in liver disease, 2018.

W. Becker, M. Saisana, P. Paruolo, and I. Vandecasteele, Weights and importance in composite indicators: Closing the gap, Ecol Indic, vol.80, pp.12-22, 2017.

A. Palayew, S. Hutchinson, H. Razavi, G. Cooke, and J. V. Lazarus, Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C, Lancet Gastroenterology and Hepatology, 2020.

P. Paruolo, M. Saisana, and A. Saltello, Ratings and rankings: voodoo or science, Journal of the Royal Statistical Society, vol.176, p.24, 2013.